Michael D Toboni

5PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersMolecular targetsMortalityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 24, 2025
Using Circulating Tumor DNA-Based Molecular Residual Disease Detection for Postoperative Monitoring in Early-Stage Uterine Cancer.

Peter W Ketch, Carly Bess Scalise, Fernando Recio

|Feb 13, 2024
Differential Responses to Immune Checkpoint Inhibitors are Governed by Diverse Mismatch Repair Gene Alterations.

Moh'd M Khushman, Michael D Toboni, Joanne Xiu

|Apr 16, 2022
Sociodemographic characteristics and cervical cancer survival in different regions of the United States: a National Cancer Database study.

Michael D Toboni, Alexander Cohen, Zachary L Gentry

|Dec 10, 2021
Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous Cancer.

Michael D Toboni, Elena Lomonosova, Shaina F Bruce

|Nov 04, 2021
New Treatments for Recurrent Uterine Cancer.

Michael D Toboni, Matthew A Powell

Pageof 1

Frequent Collaborators

1 joint publications

Angela Schab

1 joint publications

Moh'd M Khushman

1 joint publications

Joanne Xiu

1 joint publications

Upender Manne